0001628280-24-010358.txt : 20240311
0001628280-24-010358.hdr.sgml : 20240311
20240311213034
ACCESSION NUMBER: 0001628280-24-010358
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scherman Jeffrey J
CENTRAL INDEX KEY: 0001867147
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40537
FILM NUMBER: 24740047
MAIL ADDRESS:
STREET 1: C/O BRIGHT HEALTH GROUP, INC.
STREET 2: 8000 NORMAN CENTER DRIVE, SUITE 1200
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55437
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeueHealth, Inc.
CENTRAL INDEX KEY: 0001671284
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 474991296
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9250 NW 36TH STREET
STREET 2: SUITE 420
CITY: DORAL
STATE: FL
ZIP: 33178
BUSINESS PHONE: 612-238-1321
MAIL ADDRESS:
STREET 1: 9250 NW 36TH STREET
STREET 2: SUITE 420
CITY: DORAL
STATE: FL
ZIP: 33178
FORMER COMPANY:
FORMER CONFORMED NAME: Bright Health Group Inc.
DATE OF NAME CHANGE: 20210309
FORMER COMPANY:
FORMER CONFORMED NAME: Bright Health Inc.
DATE OF NAME CHANGE: 20160404
4
1
wk-form4_1710207024.xml
FORM 4
X0508
4
2024-03-07
0
0001671284
NeueHealth, Inc.
NEUE
0001867147
Scherman Jeffrey J
C/O BRIGHT HEALTH GROUP, INC.
8000 NORMAN CENTER DRIVE, SUITE 900
MINNEAPOLIS
MN
55437
0
1
0
0
Chief Accounting Officer
0
Common Stock
2024-03-07
4
M
0
1280
A
4763
D
Common Stock
2024-03-07
4
S
0
224
9.88
D
4539
D
Common Stock
2024-03-08
4
S
0
145
8.42
D
4394
D
Restricted Stock Units
2024-03-07
4
M
0
1280
0
D
Common Stock
1280
1280
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.32 to $11.05 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $9.30 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These restricted stock units vest in three equal annual installments beginning on March 7, 2023.
/s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
2024-03-11